Therefore, newer therapies that target androgen metabolizing AR are being developed and have shown clinical efficacy, indicating the continued importance of the androgen signaling axis in advanced PCa (Higano and Crawford, 2011). This evidence concerns the gene AR and posterior cortical atrophy.